Terapevt Arkh
The most recent articles from:
Terapevt Arkh
-
Comparative Study
[The antagonist of type-II serotonin receptors naftidrofuryl in the treatment of patients with intermittent claudication].
The authors' findings say about compatibility of clinical responses to naftidrofuril (daily dose 600 mg) and pentoxifillin (daily dose 600 mg) in patients with atherosclerosis of the lower limb artery and intermittent claudication stage II. Both the drugs had minimal effects on coagulant and fibrinolytic systems and platelet aggregation.
-
Biography Historical Article
[The modern view of the history of Beethoven's disease].